Acute ischemic stroke secondary to large vessel occlusion represents a critical medical emergency requiring rapid intervention. Mechanical thrombectomy has revolutionized acute stroke management by successfully restoring cerebral perfusion in salvageable brain tissue. However, clinicians often observe considerable variation in functional recovery despite prompt recanalization. Emerging scientific evidence reveals that systemic inflammation significantly influences mechanical thrombectomy outcomes. Peripheral blood biomarkers, specifically the neutrophil-to-lymphocyte ratio and lymphocyte-to-monocyte ratio, reflect the complex systemic inflammatory response triggered by cerebral ischemia. Evaluating these readily available hematologic indices allows clinicians to improve risk stratification and anticipate clinical trajectories following endovascular therapy.

Neuroinflammation and Mechanical Thrombectomy Outcomes

Ischemic cerebral injury triggers an immediate and robust neuroinflammatory cascade. Following arterial occlusion and subsequent recanalization, the damaged brain parenchyma releases danger-associated molecular patterns. Consequently, these molecules activate resident microglia and mobilize peripheral immune cells across the disrupted blood-brain barrier. Neutrophils represent the earliest circulating leukocytes to infiltrate the ischemic focus. Once inside the tissue, neutrophils release matrix metalloproteinases, reactive oxygen species, and pro-inflammatory cytokines. These destructive mediators accelerate endothelial breakdown, promote microvascular thrombosis, and aggravate ischemia-reperfusion injury. Consequently, profound neutrophilic infiltration strongly correlates with secondary tissue injury and poor functional recovery. Conversely, circulating lymphocytes promote tissue repair, modulate excessive post-stroke inflammation, and secrete neuroprotective cytokines. When lymphopenia occurs, the brain loses this essential immunomodulatory safeguard, leaving neural tissue vulnerable to unchecked cytotoxic damage.

Clinical Value of Admission NLR in Large Vessel Occlusion

The neutrophil-to-lymphocyte ratio integrates two opposing arms of the immune response into a single, cohesive parameter. Elevated admission values reflect severe innate immune activation combined with systemic stress-induced immunosuppression. Clinical studies examining anterior circulation large vessel occlusions demonstrate that elevated baseline ratios strongly correlate with unfavorable three-month modified Rankin Scale scores. Specifically, multivariable logistic regression analyses confirm this ratio as an independent predictor of poor functional recovery after adjusting for baseline stroke severity, fasting blood glucose, and symptomatic intracranial hemorrhage. Furthermore, patients presenting with marked neutrophilia and relative lymphopenia exhibit higher rates of malignant cerebral edema and early neurological deterioration. Because peripheral hemograms are universally acquired upon emergency department presentation, clinicians can rapidly calculate this parameter without delaying interventional procedures.

Prognostic Significance of LMR in Acute Stroke

The lymphocyte-to-monocyte ratio provides additional critical insights into post-ischemic immune equilibrium. Circulating monocytes migrate rapidly to ischemic tissue, differentiating into pro-inflammatory macrophages that worsen microvascular barrier integrity. In contrast, higher lymphocyte counts preserve tissue homeostasis and dampen destructive monocyte-driven inflammation. Consequently, a lower ratio indicates monocyte dominance and depleted immunoprotection. Observational investigations show that patients with lower baseline values experience significantly higher odds of three-month disability and increased mortality. Moreover, depressed ratios independently mirror severe initial neurological deficits and extensive infarct volumes. When interventional teams evaluate this ratio in conjunction with endovascular metrics, they can more accurately distinguish between patients who will thrive after reperfusion and those at elevated risk for futile recanalization.

Predicting Mechanical Thrombectomy Outcomes Through Inflammatory Markers

Combining multiple inflammatory indices significantly refines prognostication compared to individual clinical parameters alone. Receiver operating characteristic analyses reveal superior diagnostic accuracy when clinicians simultaneously evaluate both parameters alongside standard clinical scores. Specifically, the coexistence of elevated neutrophilic activity and depressed monocytic modulation signifies an aggressive inflammatory phenotype. Furthermore, this systemic imbalance predisposes patients to hemorrhagic transformation following mechanical recanalization. In clinical practice, successfully removing a clot does not guarantee complete cellular rescue. Reperfusion of injured capillaries frequently causes reperfusion injury when systemic inflammation remains unabated. Therefore, integrating these simple hematologic ratios into clinical decision-making protocols offers a practical, cost-effective framework to monitor patient vulnerability throughout the peri-procedural period.

Translating Biomarkers into Post-Thrombectomy Clinical Care

Understanding the inflammatory profile of acute stroke patients directly informs downstream therapeutic strategies and monitoring intensity. Neurocritical care teams can utilize elevated baseline inflammatory indices to identify patients requiring intensive hemodynamic stabilization, aggressive glycemic management, and rigorous neurological surveillance. In addition, recognizing heightened inflammatory risks aids in selecting individuals who might benefit most from neuroprotective adjuncts or anti-inflammatory clinical trials. Clinicians must remember that these ratios serve as risk stratification tools rather than definitive exclusion criteria for endovascular intervention. Timely endovascular revascularization remains the absolute standard of care for salvageable ischemic tissue. However, incorporating hematologic biomarkers into holistic prognostication models allows clinicians to anticipate complications, counsel families transparently, and optimize individualized post-procedure neurorehabilitation strategies.

How do baseline inflammatory ratios predict mechanical thrombectomy outcomes?

Elevated neutrophil-to-lymphocyte ratios and depressed lymphocyte-to-monocyte ratios reflect heightened systemic inflammation, severe tissue destruction, and impaired neuroprotection. Consequently, these hematologic imbalances correlate strongly with post-ischemic microvascular damage, secondary reperfusion injury, symptomatic intracranial hemorrhage, and unfavorable functional outcomes at three months, independent of successful mechanical recanalization.

Can elevated inflammatory ratios justify withholding endovascular mechanical thrombectomy?

No, elevated inflammatory ratios must never justify withholding mechanical thrombectomy. Endovascular intervention remains the proven primary standard of care for acute large vessel occlusions. Clinicians should utilize these biomarkers exclusively as supplementary prognostic indicators to guide postoperative vigilance, identify high-risk patients, and optimize individualized supportive care.

How quickly can clinicians calculate these predictive biomarkers in acute stroke?

Clinicians can calculate both ratios within minutes from routine admission complete blood counts. Because laboratory teams routinely prioritize automated hemograms during acute stroke codes, these objective indices provide rapid, inexpensive, and accessible prognostic insight without causing any procedural delay to time-critical revascularization therapies.

Disclaimer: This content is for informational and educational purposes only and should not be considered as medical advice. Healthcare professionals must exercise their independent clinical judgment. Refer to the latest local and national guidelines for clinical practice.

References

Xu R et al. NLR and LMR could powerfully predict unfavorable outcomes in patients with acute anterior circulation large vessel occlusion stroke (ALVOS) who underwent mechanical thrombectomy. Clin Neurol Neurosurg. 2025 Jul. doi: 10.1016/j.clineuro.2025.108925. PMID: 40334392.

Lux D, Alakbarzade V, Bridge L, Clark CN, Clarke B, Zhang LQ, et al. The association of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio with 3-month clinical outcome after mechanical thrombectomy following stroke. J Neuroinflammation. 2020;17(1):60.

Oh SW, Yi HJ, Lee DH, Sung JH. Prognostic Significance of Various Inflammation Based Scores in Patients with Mechanical Thrombectomy for Acute Ischemic Stroke. World Neurosurg. 2020;141:e510-e517.

Song Q, Pan R, Jin Y, et al. Lymphocyte-to-monocyte ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke. Neurol Sci. 2020;41(9):2511-2520.